Physician profile
Travis C Batts
NPI 1164646394
$457,022.85
in general payments reported to CMS, 2019-2025
7 companies · $77K in 2025
The $77K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53K · 2020: $94K · 2021: $26K · 2022: $26K · 2023: $63K · 2024: $118K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $122K · Honoraria: $67K · Travel and Lodging: $30K · Consulting Fee: $21K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $13K · Food and Beverage: $5,092 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $122,143.19 |
| Honoraria | $66,750.00 |
| Travel and Lodging | $29,854.99 |
| Consulting Fee | $20,985.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $13,475.00 |
| Food and Beverage | $5,091.67 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $292,690.96 | 2019-2025 | (1658) Clinical Educ Ultrasound, Clinical Educ Ultrasound, (1658) Clin Educ US |
| Novo Nordisk INC | $163,801.97 | 2023-2025 | Wegovy, Ozempic |
| Edwards Lifesciences Corporation | $220.81 | 2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.62 | 2025 | Lifevest |
| Chiesi USA, INC. | $98.12 | 2025 | Kengreal |
| Pfizer INC. | $87.25 | 2021 | |
| Amgen INC. | $18.12 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Batts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.